A61P 25/34
Tobacco-abuse
A61P25/34 (Tobacco-abuse) appears on 1,676 US grants and 2,792 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,676
- Published applications
- 2,792
- Assignees
- 718
- Inventors
- 4,011
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 13 | 0 |
| 2000 | 13 | 0 |
| 2001 | 30 | 13 |
| 2002 | 47 | 72 |
| 2003 | 56 | 118 |
| 2004 | 59 | 156 |
| 2005 | 49 | 157 |
| 2006 | 81 | 175 |
| 2007 | 77 | 179 |
| 2008 | 93 | 225 |
| 2009 | 95 | 242 |
| 2010 | 130 | 312 |
| 2011 | 108 | 197 |
| 2012 | 119 | 141 |
| 2013 | 108 | 98 |
| 2014 | 103 | 94 |
| 2015 | 92 | 94 |
| 2016 | 59 | 63 |
| 2017 | 64 | 61 |
| 2018 | 56 | 54 |
| 2019 | 31 | 74 |
| 2020 | 37 | 52 |
| 2021 | 37 | 51 |
| 2022 | 41 | 39 |
| 2023 | 16 | 49 |
| 2024 | 21 | 30 |
| 2025 | 21 | 31 |
| 2026 | 9 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified release formulation for (-)-(3AR,4S,7AR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester16 Jun 2026US 12,653,807 B2Novartis AG
- Optimized bio-synchronous bioactive agent delivery system9 Jun 2026US 12,649,029 B2Morningside Venture Investments Limited
- Devices for evaporation and inhalation of nicotine26 May 2026US 12,636,446 B2Emplicure AB
- Multi-phase delivery compositions and products incorporating such compositions19 May 2026US 12,629,361 B2Modoral Brands Inc.
- Cytisine salts28 Apr 2026US 12,612,406 B2Achieve Life Sciences, Inc.
- Compositions comprising psilocybin, optionally in combination with n-acylethanolamines and uses thereof13 Aug 2026US 2026/0232702 A1Clearmind Labs Corp.
- Microspheres comprising high-dose varenicline, method for preparing same, and pharmaceutical composition comprising same6 Aug 2026US 2026/0224491 A1Aulbio Co., Ltd.
- Pharmaceutical composition comprising cytisine30 Jul 2026US 2026/0216153 A1Adamed Pharma S.A.
- Alkaline intraoral formulations23 Jul 2026US 2026/0207487 A1Emplicure AB (publ)
- Combination of dextromethorphan and bupropion for treating depression16 Jul 2026US 2026/0199265 A1Antecip Bioventures II LLC
Most cited
By later US patents
- Electronic atomization cigarette779US 7,832,410 B2Best Partners Worldwide Limited · 2010
- Method of preventing abuse of opioid dosage forms391US 6,228,863 B1Euro-Celtique S. A. · 2001
- Electronic atomization cigarette316US 8,393,331 B2Ruyan Investment (Holdings) Limited · 2013
- Method of preventing abuse of opioid dosage forms247US 6,627,635 B2Euro-Celtique S. A. · 2003
- Bupropion metabolites and methods of use151US 6,342,496 B12002